Gastrointestinal Over-The-Counter (OTC) Drugs Market by Product, Distribution Channel, and Geography - Forecast and Analysis 2023-2027
| Published: May 2023 | Pages: 177 | SKU: IRTNTR75270 |
The Gastrointestinal Over-The-Counter (OTC) Drugs Market size is estimated to grow at a CAGR of 5.29% between 2022 and 2027. The market size is forecasted to increase by USD 4,759.86 million. The growth of the market depends on several factors, including the increase in the prevalence of gastrointestinal disorders, the rise in the adoption of gastrointestinal OTC drugs due to easy availability and affordability, and the availability of multiple payment options.
This Gastrointestinal Over-The-Counter Drugs Market report extensively covers market segmentation by product (antacid, laxatives, anti-diarrheal, anti-emetics, and others), distribution channel (offline and online), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will be the Size of the Gastrointestinal OTC Drugs Market During the Forecast Period?
To learn more about this report, View Report Sample
Gastrointestinal OTC Drugs Market: Key Drivers, Trends, Challenges, and Customer Landscape
The increase in the prevalence of gastrointestinal disorders is notably driving the Gastrointestinal Over-The-Counter (OTC) Drugs Market growth, although factors such as the risk of taking the wrong medication due to incorrect self-diagnosis may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Gastrointestinal OTC Drugs Market Driver
The increase in the prevalence of gastrointestinal disorders is notably driving the Gastrointestinal Over-The-Counter (OTC) Drugs Market growth. Gastrointestinal disorders refer to a group of medical conditions that affect the digestive/gastrointestinal system. The prevalence of gastrointestinal disorders has increased worldwide over the last few years, which has increased healthcare costs and decreased the quality of life of people. Changes in lifestyles and eating habits are some of the primary causes of these disorders. The consumption of processed and fast food has increased in recent years, leading to gastrointestinal disorders. The rise in stress levels also contributes to the increase in gastrointestinal disorders. Stress can cause conditions such as irritable bowel syndrome, ulcers, and acid reflux.
The rise in the prevalence of gastrointestinal disorders has an impact on individual patients and their families. Patients can experience chronic pain, loss of appetite, and reduced quality of life. Gastrointestinal disorders can also be life-threatening in some cases. These factors are expected to increase the demand for gastrointestinal OTC drugs worldwide, which, in turn, is expected to propel the growth of the global gastrointestinal OTC drugs market during the forecast period.
Significant Gastrointestinal OTC Drugs Market Trends
The increase in the adoption of online platforms for gastrointestinal OTC drugs is a key trend shaping the market. The popularity of online platforms has increased as they offer convenience, accessibility, and various options to consumers. These platforms provide detailed information about each drug, including the ingredients, dosage, and possible side effects, which helps buyers make informed decisions. Consumers can also read reviews from other buyers.
Online platforms also provide home delivery options. For example, Amazon offers a wide range of gastrointestinal OTC drugs, such as antacids, laxatives, and anti-diarrhea medications, that can be delivered within a day. It also provides information on different gastrointestinal issues, such as heartburn, indigestion, and constipation. Walgreens and CVS provide similar services. These factors are expected to fuel the growth of the market during the forecast period.
Major Gastrointestinal OTC Drugs Market Challenge
The risk of taking the wrong medication due to incorrect self-diagnosis may impede market growth. There are various gastrointestinal OTC drugs that do not require a prescription. However, incorrect self-diagnosis of the condition may lead the patient to take the wrong medication. Patients may not have adequate knowledge or expertise to differentiate between different gastrointestinal conditions. This can lead to unwanted side effects, prolonged discomfort, and serious complications.
Patients often fail to follow the instructions provided on OTC drugs, which can lead to incorrect dosage and timing. This can also lead to dangerous drug interactions or adverse effects. Moreover, patients may not be aware of the use of certain OTC gastrointestinal drugs. For example, antacids are commonly used to relieve indigestion or heartburn, but they are counter-indicated in patients who may have an undiagnosed peptic ulcer. These factors are expected to hinder the growth of the market during the forecast period.
Key Gastrointestinal OTC Drugs Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Gastrointestinal OTC Drugs Market Customer Landscape
Who are the Major Gastrointestinal OTC Drugs Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers gastrointestinal OTC drugs such as Pantoprazole.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- AbbVie Inc.
- Bausch Health Co. Inc.
- Bayer AG
- Cipla Ltd.
- Dr Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- GlaxoSmithKline Plc
- Haleon Plc
- Johnson and Johnson Services Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Phathom Pharmaceuticals Inc.
- Prestige Consumer Healthcare Inc.
- Sanofi SA
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Gastrointestinal OTC Drugs Market?
The market share growth by the antacid segment will be significant during the forecast period. Antacids are used to treat symptoms of acid reflux, indigestion, and heartburn, which are caused by an increase in the acidity of the stomach. They work by neutralizing the acid, thereby relieving these symptoms. Antacids are available in various forms, such as tablets, capsules, suspensions, and chewable tablets. The growth of this segment is attributed to factors such as the increasing prevalence of gastrointestinal disorders worldwide.
Get a glance at the market contribution of various segments View the PDF Sample
The antacid segment was valued at USD 6,469.55 million in 2017 and continued to grow until 2021. The prevalence of gastrointestinal disorders is increasing, owing to factors such as unhealthy eating habits, stressful lifestyles, and the use of non-steroidal anti-inflammatory drugs (NSAIDs). This is driving the demand for antacids. The easy access to healthcare and self-medication practices are also contributing to the growth of the antacid segment.
Which are the Key Regions for the Gastrointestinal OTC Drugs Market?
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The demand for OTC drugs, especially for gastrointestinal issues such as irritable bowel syndrome (IBS), constipation, diarrhea, and acid reflux, is increasing in North America. This growth is attributed to various factors, such as a sedentary lifestyle, unhealthy eating habits, and rising stress levels. In addition, the increasing geriatric population in North America is leading to a rise in the demand for gastrointestinal OTC drugs. The presence of advanced healthcare infrastructure and leading pharmaceutical companies also contribute to the growth of the Gastrointestinal Over-The-Counter Drugs Market in the region.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The COVID-19 pandemic had a negative impact on the sales of gastrointestinal OTC drugs in North America in 2020 and early 2021. However, by the second quarter of 2021, lockdown restrictions were relaxed with the introduction of COVID-19 vaccination across various countries. The rising number of clinical trials and approvals by the US FDA for gastrointestinal OTC drugs, the increase in the prevalence of gastrointestinal diseases, the growth in healthcare expenditure, and the rise in the number of advanced healthcare facilities are expected to drive Gastrointestinal Over-The-Counter Drugs Market growth in the region during the forecast period.
Segment Overview
The Gastrointestinal OTC Drugs Market report forecasts market growth by revenue at global, regional, & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Product Outlook (USD Million, 2017 - 2027)
- Antacid
- Laxatives
- Anti-diarrheal
- Anti-emetics
- Others
- Distribution Channel Outlook (USD Million, 2017 - 2027)
- Offline
- Online
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Australia
- Argentina
- Rest of the world
- North America
Parent Market Analysis
Technavio categorizes the Gastrointestinal OTC Drugs Market as a part of the global pharmaceuticals market within the overall healthcare industry. The parent market, the global pharmaceuticals market, covers products and companies engaged in the R&D or production of generic drugs, non-generic drugs, and veterinary drugs. Technavio calculates the global healthcare market size based on the combined revenue generated by manufacturers/providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.
|
Gastrointestinal OTC Drugs Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
177 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.29% |
|
Market growth 2023-2027 |
USD 4,759.86 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
4.77 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, Germany, France, China, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, AbbVie Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., Zoic Pharmaceuticals Pvt. Ltd., and Boehringer Ingelheim International GmbH |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Gastrointestinal OTC Drugs Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the size of the market size and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of market vendors
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global gastrointestinal OTC drugs market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global gastrointestinal otc drugs market 2017 - 2021 ($ million)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.3 Distribution Channel Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Antacid - Market size and forecast 2022-2027
- Exhibit 34: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Antacid - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
- 6.4 Laxatives - Market size and forecast 2022-2027
- Exhibit 38: Chart on Laxatives - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Laxatives - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Laxatives - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Laxatives - Year-over-year growth 2022-2027 (%)
- 6.5 Anti-diarrheal - Market size and forecast 2022-2027
- Exhibit 42: Chart on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
- 6.6 Anti-emetics - Market size and forecast 2022-2027
- Exhibit 46: Chart on Anti-emetics - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Anti-emetics - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Anti-emetics - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Anti-emetics - Year-over-year growth 2022-2027 (%)
- 6.7 Others - Market size and forecast 2022-2027
- Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 6.8 Market opportunity by Product
- Exhibit 54: Market opportunity by Product ($ million)
- Exhibit 55: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
- 7.2 Comparison by Distribution Channel
- Exhibit 58: Chart on Comparison by Distribution Channel
- Exhibit 59: Data Table on Comparison by Distribution Channel
- 7.3 Offline - Market size and forecast 2022-2027
- Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
- 7.4 Online - Market size and forecast 2022-2027
- Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
- Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Distribution Channel
- Exhibit 68: Market opportunity by Distribution Channel ($ million)
- Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2022-2027 (%)
- Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 China - Market size and forecast 2022-2027
- Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.9 Japan - Market size and forecast 2022-2027
- Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.10 Germany - Market size and forecast 2022-2027
- Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.11 France - Market size and forecast 2022-2027
- Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ million)
- Exhibit 112: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 116: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 117: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification
- 12.3 Abbott Laboratories
- Exhibit 119: Abbott Laboratories - Overview
- Exhibit 120: Abbott Laboratories - Business segments
- Exhibit 121: Abbott Laboratories - Key news
- Exhibit 122: Abbott Laboratories - Key offerings
- Exhibit 123: Abbott Laboratories - Segment focus
- 12.4 AbbVie Inc.
- Exhibit 124: AbbVie Inc. - Overview
- Exhibit 125: AbbVie Inc. - Product / Service
- Exhibit 126: AbbVie Inc. - Key news
- Exhibit 127: AbbVie Inc. - Key offerings
- 12.5 Bausch Health Co. Inc.
- Exhibit 128: Bausch Health Co. Inc. - Overview
- Exhibit 129: Bausch Health Co. Inc. - Business segments
- Exhibit 130: Bausch Health Co. Inc. - Key news
- Exhibit 131: Bausch Health Co. Inc. - Key offerings
- Exhibit 132: Bausch Health Co. Inc. - Segment focus
- 12.6 Bayer AG
- Exhibit 133: Bayer AG - Overview
- Exhibit 134: Bayer AG - Business segments
- Exhibit 135: Bayer AG - Key news
- Exhibit 136: Bayer AG - Key offerings
- Exhibit 137: Bayer AG - Segment focus
- 12.7 Boehringer Ingelheim International GmbH
- Exhibit 138: Boehringer Ingelheim International GmbH - Overview
- Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 140: Boehringer Ingelheim International GmbH - Key news
- Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
- 12.8 Cipla Ltd.
- Exhibit 143: Cipla Ltd. - Overview
- Exhibit 144: Cipla Ltd. - Business segments
- Exhibit 145: Cipla Ltd. - Key news
- Exhibit 146: Cipla Ltd. - Key offerings
- Exhibit 147: Cipla Ltd. - Segment focus
- 12.9 Dr Reddys Laboratories Ltd.
- Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus
- 12.10 GlaxoSmithKline Plc
- Exhibit 152: GlaxoSmithKline Plc - Overview
- Exhibit 153: GlaxoSmithKline Plc - Business segments
- Exhibit 154: GlaxoSmithKline Plc - Key news
- Exhibit 155: GlaxoSmithKline Plc - Key offerings
- Exhibit 156: GlaxoSmithKline Plc - Segment focus
- 12.11 Haleon Plc
- Exhibit 157: Haleon Plc - Overview
- Exhibit 158: Haleon Plc - Business segments
- Exhibit 159: Haleon Plc - Key offerings
- Exhibit 160: Haleon Plc - Segment focus
- 12.12 Johnson and Johnson Services Inc.
- Exhibit 161: Johnson and Johnson Services Inc. - Overview
- Exhibit 162: Johnson and Johnson Services Inc. - Business segments
- Exhibit 163: Johnson and Johnson Services Inc. - Key news
- Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
- Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
- 12.13 Novartis AG
- Exhibit 166: Novartis AG - Overview
- Exhibit 167: Novartis AG - Business segments
- Exhibit 168: Novartis AG - Key offerings
- Exhibit 169: Novartis AG - Segment focus
- 12.14 Pfizer Inc.
- Exhibit 170: Pfizer Inc. - Overview
- Exhibit 171: Pfizer Inc. - Product / Service
- Exhibit 172: Pfizer Inc. - Key news
- Exhibit 173: Pfizer Inc. - Key offerings
- 12.15 Prestige Consumer Healthcare Inc.
- Exhibit 174: Prestige Consumer Healthcare Inc. - Overview
- Exhibit 175: Prestige Consumer Healthcare Inc. - Business segments
- Exhibit 176: Prestige Consumer Healthcare Inc. - Key offerings
- Exhibit 177: Prestige Consumer Healthcare Inc. - Segment focus
- 12.16 Sanofi SA
- Exhibit 178: Sanofi SA - Overview
- Exhibit 179: Sanofi SA - Business segments
- Exhibit 180: Sanofi SA - Key news
- Exhibit 181: Sanofi SA - Key offerings
- Exhibit 182: Sanofi SA - Segment focus
- 12.17 Takeda Pharmaceutical Co. Ltd.
- Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 184: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 185: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 186: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 187: Inclusions checklist
- Exhibit 188: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 189: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 190: Research methodology
- Exhibit 191: Validation techniques employed for market sizing
- Exhibit 192: Information sources
- 13.5 List of abbreviations
- Exhibit 193: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
gastrointestinal otc drugs market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis